Vice President, Global Commercialization Partnerships
Revolution Medicines — US
Full-Time
Aug 8, 2026
$5,654 - $7,058/week
Apply Now →
About This Position
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) …
Frequently Asked Questions
How do I apply?
Click the Apply Now button to submit your application directly to the employer.
What is the salary?
The estimated compensation for this role is $5,654 - $7,058/week.
Is this remote?
Check the job description for location requirements.
Job Details
Company
Revolution Medicines
Revolution Medicines
Location
US
US
Type
Full-Time
Full-Time
Salary
$5,654 - $7,058/week
$5,654 - $7,058/week
Posted
08/08/2026
Quick Apply
08/08/2026
Similar Jobs
RN Transfer Center
St. Luke's Health System
Lead, Info Security Systems Engineer
L3Harris Technologies
Occupational Therapist
ESC of Eastern Ohio Consortium